MARK L PERRY

CIK 1190270 · last filed 2024-06-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.00M

Companies

3

Total Filings

53

Lifetime Open-Market Net

-$55.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NVDA Director 14,612 $205.19 $3.00M -$51.09M 30 2024-06-26
Global Blood Therapeutics, Inc. (GBT) Delisted Director 0 $68.49 $0 -$4.09M 11 2022-10-06
MyoKardia, Inc. (MYOK) Delisted Director 27,708 $50.0K 9 2020-06-23

Recent Filings · Page 2 of 6

53 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-21 Global Blood Therapeutics, Inc. (GBT) Delisted Mixed +3,037 $0 EDGAR
2021-06-08 NVDA Grant (A) +429 $0 EDGAR
2021-04-06 NVDA Sell (S) −6,104 -$3.40M EDGAR
2020-11-19 Mixed −29,508 $0
2020-06-23 MyoKardia, Inc. (MYOK) Delisted Exer (M) +2,300 $0 EDGAR
2020-06-22 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
2020-06-19 Global Blood Therapeutics, Inc. (GBT) Delisted Mixed +4,800 $0 EDGAR
2020-06-16 MyoKardia, Inc. (MYOK) Delisted Exer (M) +2,300 $0 EDGAR
2020-06-12 NVDA Grant (A) +712 $0 EDGAR
2020-05-29 NVDA Sell (S) −12,208 -$4.07M EDGAR
Showing 1120 of 53
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.